GSA Capital Partners LLP Has $1.09 Million Stock Position in Viemed Healthcare, Inc. (NASDAQ:VMD)

Key Points

• GSA Capital Partners LLP significantly increased its stake in Viemed Healthcare, Inc. by 497.7% in the first quarter, acquiring an additional 124,731 shares to own 149,791 shares valued at approximately $1,090,000.
• Other institutional investors also enhanced their positions in Viemed Healthcare, with hedge funds owning 74.24% of the company, highlighting a strong interest from larger financial players.
• Viemed Healthcare reported $0.06 earnings per share for the last quarter, matching expectations, with revenues totaling $59.1 million, slightly below consensus estimates.

GSA Capital Partners LLP raised its position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 497.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 149,791 shares of the company's stock after purchasing an additional 124,731 shares during the quarter. GSA Capital Partners LLP owned about 0.38% of Viemed Healthcare worth $1,090,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Corton Capital Inc. increased its stake in Viemed Healthcare by 45.4% during the 1st quarter. Corton Capital Inc. now owns 14,842 shares of the company's stock worth $108,000 after buying an additional 4,634 shares during the period. BCM Advisors LLC increased its holdings in shares of Viemed Healthcare by 10.6% in the first quarter. BCM Advisors LLC now owns 23,520 shares of the company's stock valued at $173,000 after purchasing an additional 2,250 shares during the period. Segall Bryant & Hamill LLC boosted its holdings in shares of Viemed Healthcare by 252.1% in the first quarter. Segall Bryant & Hamill LLC now owns 130,229 shares of the company's stock valued at $948,000 after acquiring an additional 93,242 shares in the last quarter. Victory Capital Management Inc. raised its holdings in Viemed Healthcare by 45.8% during the first quarter. Victory Capital Management Inc. now owns 158,198 shares of the company's stock worth $1,152,000 after purchasing an additional 49,701 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in Viemed Healthcare by 12.2% in the 1st quarter. Bank of New York Mellon Corp now owns 80,141 shares of the company's stock valued at $583,000 after purchasing an additional 8,711 shares in the last quarter. Institutional investors and hedge funds own 74.24% of the company's stock.

Insider Activity at Viemed Healthcare

In related news, Director Nitin Kaushal sold 34,100 shares of the stock in a transaction dated Friday, June 27th. The shares were sold at an average price of $7.01, for a total value of $239,041.00. Following the completion of the sale, the director owned 126,843 shares in the company, valued at approximately $889,169.43. This trade represents a 21.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 20.00% of the stock is currently owned by company insiders.

Viemed Healthcare Price Performance

Shares of VMD stock traded up $0.14 during trading hours on Monday, hitting $6.07. The company's stock had a trading volume of 141,166 shares, compared to its average volume of 158,133. The company has a current ratio of 1.38, a quick ratio of 1.26 and a debt-to-equity ratio of 0.03. The business has a fifty day moving average of $6.67 and a 200-day moving average of $7.12. Viemed Healthcare, Inc. has a twelve month low of $5.93 and a twelve month high of $9.81. The stock has a market cap of $239.69 million, a price-to-earnings ratio of 20.23 and a beta of 1.33.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.06. The company had revenue of $59.10 million for the quarter, compared to analyst estimates of $60.60 million. Viemed Healthcare had a net margin of 5.28% and a return on equity of 9.49%.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.